AR066014A1 - Difenil- dihidro -imidazopiridinonas. composiciones farmaceuticas y usos. - Google Patents
Difenil- dihidro -imidazopiridinonas. composiciones farmaceuticas y usos.Info
- Publication number
- AR066014A1 AR066014A1 ARP080101487A ARP080101487A AR066014A1 AR 066014 A1 AR066014 A1 AR 066014A1 AR P080101487 A ARP080101487 A AR P080101487A AR P080101487 A ARP080101487 A AR P080101487A AR 066014 A1 AR066014 A1 AR 066014A1
- Authority
- AR
- Argentina
- Prior art keywords
- heterocycle
- substituted
- group
- heteroaryl
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Estos compuestos inhiben la interaccion de la proteína MDM2 con un péptido de tipo p-53 y, por lo tanto, poseen una actividad antiproliferante. Reivindicacion 1: Un compuesto de la fámula (1) en la que Y1 e Y2 se eligen con independencia entre elgrupo formado por halogeno, trifluormetilo, -NO2, -C:::N, y -C:::CH; X se elige entre el grupo formado por -SO2, -C=O y -.C=OCH2-, R1 se elige entre el grupo formado por hidrogeno, alquilo sustituido por heterociclo, dicho heterociclo puede estarsustituido por (C=O)Me, halogeno, arilo, arilo sustituido, heterociclo, heterociclo sustituido, heteroarilo, heteroarilo sustituido, alquenilo y C=OR3 en el que R3 es H, alcoxi, amino, cicloamino, heterociclo o heterociclo sustituido; R2 se eligeentre el grupo formado por alquilo sustituido o sin sustituir, cicloalquilo, arilo, heteroarilo y heterociclo y sus sales y ésteres farmacéuticamente aceptables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92311007P | 2007-04-12 | 2007-04-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR066014A1 true AR066014A1 (es) | 2009-07-15 |
Family
ID=39478351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080101487A AR066014A1 (es) | 2007-04-12 | 2008-04-10 | Difenil- dihidro -imidazopiridinonas. composiciones farmaceuticas y usos. |
Country Status (18)
Country | Link |
---|---|
US (1) | US7625895B2 (es) |
EP (1) | EP2146986B1 (es) |
JP (1) | JP2010523616A (es) |
KR (1) | KR20090118116A (es) |
CN (1) | CN101657449B (es) |
AR (1) | AR066014A1 (es) |
AT (1) | ATE514696T1 (es) |
AU (1) | AU2008238062A1 (es) |
BR (1) | BRPI0810495A2 (es) |
CA (1) | CA2684008A1 (es) |
CL (1) | CL2008001047A1 (es) |
ES (1) | ES2367228T3 (es) |
IL (1) | IL201021A0 (es) |
MX (1) | MX2009011019A (es) |
PE (1) | PE20090229A1 (es) |
RU (1) | RU2009141522A (es) |
TW (1) | TW200848033A (es) |
WO (1) | WO2008125487A1 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2380892T3 (da) | 2009-01-16 | 2014-06-30 | Daiichi Sankyo Co Ltd | Imidazothiazolderivat med prolinringstruktur |
NZ600430A (en) | 2009-11-12 | 2014-06-27 | Univ Michigan | Spiro-oxindole mdm2 antagonists |
US10159669B2 (en) * | 2010-03-02 | 2018-12-25 | Ian H. Chan | Individual and combination of mdivi-1 and nutlin-3 for topical or intravitreal ophthalmic use |
JO2998B1 (ar) | 2010-06-04 | 2016-09-05 | Amgen Inc | مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان |
FR2967072B1 (fr) | 2010-11-05 | 2013-03-29 | Univ Dundee | Procede pour ameliorer la production de virus et semences vaccinales influenza |
EA201390682A1 (ru) | 2010-11-12 | 2014-01-30 | Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган | Спирооксиндольные антагонисты mdm2 |
JP2014513699A (ja) | 2011-05-11 | 2014-06-05 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | スピロ−オキシインドールmdm2アンタゴニスト |
CA2850166C (en) | 2011-09-27 | 2019-12-03 | Amgen Inc. | Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer |
CA2895504A1 (en) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
US11407721B2 (en) | 2013-02-19 | 2022-08-09 | Amgen Inc. | CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer |
MX368703B (es) | 2013-02-28 | 2019-10-11 | Amgen Inc | Un inhibidor de mdm2 derivado de acido benzoico para el tratamiento del cancer. |
WO2014151863A1 (en) | 2013-03-14 | 2014-09-25 | Amgen Inc. | Heteroaryl acid morpholinone compounds as mdm2 inhibitors for the treatment of cancer |
JOP20200296A1 (ar) | 2013-06-10 | 2017-06-16 | Amgen Inc | عمليات صنع وأشكال بلورية من mdm2 مثبط |
DK3068393T5 (da) | 2013-11-11 | 2022-08-22 | Amgen Inc | Kombinationsterapi som inkluderer en mdm2-inhibitor og et eller flere yderligere farmaceutisk aktive midler til behandlingen af kræftformer |
US20170216286A1 (en) | 2014-01-28 | 2017-08-03 | Mayo Foundation For Medical Education And Research | Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid |
CA2939121C (en) | 2014-01-28 | 2020-11-24 | Mayo Foundation For Medical Education And Research | Effective treatment of osteoarthritis, pulmonary disease, ophthalmic disease, and atherosclerosis by removing senescent cells at the site of the disease |
US10328058B2 (en) | 2014-01-28 | 2019-06-25 | Mayo Foundation For Medical Education And Research | Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques |
CA3020281A1 (en) | 2016-04-06 | 2017-10-12 | The Regents Of The University Of Michigan | Monofunctional intermediates for ligand-dependent target protein degradation |
US11192898B2 (en) | 2016-04-06 | 2021-12-07 | The Regents Of The University Of Michigan | MDM2 protein degraders |
PL3458101T3 (pl) | 2016-05-20 | 2021-05-31 | F. Hoffmann-La Roche Ag | Koniugaty PROTAC-przeciwciało i sposoby ich stosowania |
JP2022504541A (ja) | 2018-10-08 | 2022-01-13 | ザ リージェンツ オブ ザ ユニバーシティー オブ ミシガン | 低分子mdm2タンパク質デグレーダー |
EP4121043A1 (en) | 2020-03-19 | 2023-01-25 | Kymera Therapeutics, Inc. | Mdm2 degraders and uses thereof |
WO2023056069A1 (en) | 2021-09-30 | 2023-04-06 | Angiex, Inc. | Degrader-antibody conjugates and methods of using same |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1067079A (en) * | 1976-07-22 | 1979-11-27 | Yamanouchi Pharmaceutical Co. | Nitrogen-containing heterobicyclic compounds |
JPH02101065A (ja) | 1988-10-06 | 1990-04-12 | Tanabe Seiyaku Co Ltd | イミダゾリン誘導体及びその製法 |
GB9704762D0 (en) * | 1997-03-07 | 1997-04-23 | Zeneca Ltd | Chemical process |
GB2351082A (en) | 1999-06-18 | 2000-12-20 | Lilly Forschung Gmbh | Synthesis of Cyclic Substituted Amidines |
EP1463501B1 (en) * | 2001-12-18 | 2008-06-11 | F. Hoffmann-La Roche AG | Cis-imidazolines as mdm2 inhibitors |
JP4477351B2 (ja) | 2001-12-18 | 2010-06-09 | エフ.ホフマン−ラ ロシュ アーゲー | シス−2,4,5−トリフェニル−イミダゾリン類及び腫瘍の処理へのそれらの使用 |
EP1638942A1 (en) * | 2003-06-17 | 2006-03-29 | F. Hoffmann-La Roche Ag | Cis-2,4,5-triaryl-imidazolines |
ATE414693T1 (de) | 2004-05-18 | 2008-12-15 | Hoffmann La Roche | Neuartige cis-imidazoline |
US7893278B2 (en) | 2004-06-17 | 2011-02-22 | Hoffman-La Roche Inc. | CIS-imidazolines |
CN101370799B (zh) | 2006-01-18 | 2012-09-05 | 霍夫曼-拉罗奇有限公司 | 作为mdm2抑制剂的顺-4,5-二芳基-2-杂环-咪唑啉 |
JP5385125B2 (ja) | 2006-03-22 | 2014-01-08 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | MDM2とp53の間の相互作用の阻害剤 |
-
2008
- 2008-03-18 US US12/050,235 patent/US7625895B2/en not_active Expired - Fee Related
- 2008-04-02 ES ES08735669T patent/ES2367228T3/es active Active
- 2008-04-02 RU RU2009141522/04A patent/RU2009141522A/ru not_active Application Discontinuation
- 2008-04-02 CA CA002684008A patent/CA2684008A1/en not_active Abandoned
- 2008-04-02 AU AU2008238062A patent/AU2008238062A1/en not_active Abandoned
- 2008-04-02 EP EP08735669A patent/EP2146986B1/en not_active Not-in-force
- 2008-04-02 AT AT08735669T patent/ATE514696T1/de not_active IP Right Cessation
- 2008-04-02 WO PCT/EP2008/053903 patent/WO2008125487A1/en active Application Filing
- 2008-04-02 CN CN2008800116778A patent/CN101657449B/zh not_active Expired - Fee Related
- 2008-04-02 KR KR1020097021151A patent/KR20090118116A/ko not_active Application Discontinuation
- 2008-04-02 MX MX2009011019A patent/MX2009011019A/es active IP Right Grant
- 2008-04-02 JP JP2010502490A patent/JP2010523616A/ja active Pending
- 2008-04-02 BR BRPI0810495A patent/BRPI0810495A2/pt not_active IP Right Cessation
- 2008-04-10 AR ARP080101487A patent/AR066014A1/es not_active Application Discontinuation
- 2008-04-10 PE PE2008000636A patent/PE20090229A1/es not_active Application Discontinuation
- 2008-04-11 CL CL2008001047A patent/CL2008001047A1/es unknown
- 2008-04-11 TW TW097113385A patent/TW200848033A/zh unknown
-
2009
- 2009-09-17 IL IL201021A patent/IL201021A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL201021A0 (en) | 2010-05-17 |
CA2684008A1 (en) | 2008-10-23 |
AU2008238062A1 (en) | 2008-10-23 |
TW200848033A (en) | 2008-12-16 |
ATE514696T1 (de) | 2011-07-15 |
BRPI0810495A2 (pt) | 2018-10-30 |
WO2008125487A1 (en) | 2008-10-23 |
EP2146986B1 (en) | 2011-06-29 |
MX2009011019A (es) | 2009-10-29 |
US20080255119A1 (en) | 2008-10-16 |
JP2010523616A (ja) | 2010-07-15 |
EP2146986A1 (en) | 2010-01-27 |
RU2009141522A (ru) | 2011-05-20 |
US7625895B2 (en) | 2009-12-01 |
CL2008001047A1 (es) | 2009-01-16 |
PE20090229A1 (es) | 2009-03-27 |
CN101657449A (zh) | 2010-02-24 |
CN101657449B (zh) | 2012-06-06 |
KR20090118116A (ko) | 2009-11-17 |
ES2367228T3 (es) | 2011-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR066014A1 (es) | Difenil- dihidro -imidazopiridinonas. composiciones farmaceuticas y usos. | |
AR078163A1 (es) | Utilizacion de aminodihidrotiazinas para el tratamiento o prevencion de la diabetes | |
EA200970510A1 (ru) | Гетеромоноциклическое соединение и его применение | |
RU2448976C2 (ru) | Ингибиторы hcv/вич и их применение | |
AR062786A1 (es) | Benzoxasoles 2-7-disustituidos, composiciones farmaceuticas que los contienen, metodo de preparacion y usos como agentes antiproliferativos. | |
AR085960A1 (es) | 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2 | |
AR076067A1 (es) | Composiciones y metodos para modular la senda de senalizacion de wnt | |
CO6382110A2 (es) | Compuestos para el tratamiento de la hepatitis c. | |
AR077935A1 (es) | Derivados de 3-amino-5 fenil-5,6-dihidro-2h-(1,4)oxazina | |
HUP0401784A2 (hu) | Heterobiciklikus szerkezetû virális polimeráz inhibitorok, eljárás az elõállításukra, köztitermékek és ezeket tartalmazó gyógyszerkészítmények | |
ECSP10010473A (es) | Nuevos derivados de carbazol, inhibidores de hsp90, composiciones que los contienen y utilización | |
PE20040164A1 (es) | Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas | |
PE20121479A1 (es) | Inhibidores del virus de la hepatitis c | |
AR050932A1 (es) | Amidas biciclicas como inhibidores de cinasa | |
AR072952A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
AR051995A1 (es) | Derivados de tieno-piridina como intensificadores alostericos de gaba -b | |
AR074459A1 (es) | Pirrolopirazinil-ureas utiles para el tratamiento de enfermedades autoinmunes e inflamatorias. | |
AR083849A1 (es) | Antagonistas de mdm2 de espiro-oxindol | |
AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
UY30392A1 (es) | Compuestos de oximilo macrociclico inhibidores de proteasa de hepatitis c | |
UY30897A1 (es) | Derivados de pentafluorotiobenzamidoacetonitrilo, composiciones conteniéndolos y aplicaciones | |
AR079130A1 (es) | Compuestos inhibidores de la hepatitis c | |
ECSP088731A (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
CO6230986A2 (es) | Compuesto de 4-piridinona y su uso para cancer | |
PE20110546A1 (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk) y produccion de los mismos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |